Guardion health sciences, inc. (GHSI)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15
Operating Activities
Net loss

-10,878

-7,767

-5,305

-5,748

-8,841

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

477

295

118

60

53

Amortization of debt discount

250

-

-

431

642

Amortization of lease right

148

-

-

-

-

Accrued interest expense included in notes payable

-

0

8

-

-

Change in fair value of note

-

-

-

-698

0

Accrued interest expense included in notes payable

0

-

-

86

110

Stock-based compensation

378

1,595

1,932

787

2,400

Stock-based compensation - officer and director

2,339

-

-

-

-

Goodwill impairment

1,563

-

-

-

-

Non-cash financing costs - derivative liability

415

-

-

-

-

Stock-based compensation – related parties

-

0

183

982

2,485

Change in fair value of derivative warrants

-292

1,621

0

575

0

Management fee compensation expense

-

-

-

191

0

Loss on settlement of promissory notes payable and accounts payable

-

-

-

-249

-258

Inducement expense on conversions of notes payable to equity

-

-

-

-

1,699

Warrants issued in payment of accounts payable

-

-

-

-

7

Changes in operating assets and liabilities:
(Increase) decrease in -
Accounts receivable

50

-44

20

0

0

Inventories

-47

203

17

13

6

Deposits and prepaid expenses

315

-68

87

-14

9

Increase (decrease) in -
Accounts payable and accrued expenses

-14

102

-121

84

76

Lease liability

140

-

-

-

-

Accrued and deferred rent costs

40

69

-76

-54

-17

Net cash used in operating activities

-6,030

-4,173

-3,403

-1,653

-

Investing Activities
Net cash used in operating activities

-

-

-

-

-1,139

Purchase of property and equipment

171

260

37

3

2

Purchase of intellectual property

-

50

0

-

-

Cash assumed upon acquisition

-

0

4

0

-

Net cash used in investing activities

-171

-310

-32

-3

-

Financing Activities
Proceeds from issuance of preferred stock

-

0

3,105

1,145

0

Proceeds from issuance of common stock

16,224

850

5,000

0

-

Net cash used in investing activities

-

-

-

-

-2

Proceeds from issuance of convertible notes

250

-

-

136

542

Proceeds from issuance of promissory notes - related party

-

-

-

140

200

Proceeds from issuance of promissory notes

100

0

100

220

100

Payments on promissory note

100

0

149

151

0

Proceeds from exercise of warrants

171

16

0

-

75

Payments on line of credit

-

30

1

0

-

Deferred financing costs of IPO

-

270

0

-

-

Decrease in due to related parties

-

-146

54

215

232

Net cash provided by financing activities

16,645

419

8,108

1,705

-

Net cash provided by financing activities

-

-

-

-

1,149

Cash:
Net increase (decrease)

10,444

-

-

-

-

Net decrease

-

-4,064

4,672

48

7

Supplemental disclosure of cash flow information:
Interest

-

0

23

0

-

Cash paid for - Income taxes

-

0

0

-

-

Cash paid for - Interest

-

-

-

-

0

Income taxes

-

-

-

0

0

Non-cash financing activities:
Fair value of warrants issued in connection with convertible notes

436

-

-

-

-

Recording of lease asset and liability upon adoption of ASU 2016-02

721

-

-

-

-

Reclass of warrant liability to equity

359

-

-

-

-

Fair value of common stock issued upon conversion of convertible notes and accrued interest

250

-

-

-

-

Reclass of deferred offering costs to equity

270

-

-

-

-

Issuance of common stock dividends on preferred stock

-

0

308

35

0

Issuance of common stock upon conversion of accrued management fees

-

-

-

410

-

Issuance of preferred stock upon conversion of notes payable and related interest

-

-

-

535

0

Issuance of common stock upon conversion of notes payable and related interest

-

0

13

687

2,412

Fair value of warrants issued in connection with promissory and convertible notes payable

-

-

-

270

198

Beneficial conversion feature associated with promissory and convertible notes payable

-

-

-

70

25

Intangible assets

-

0

674

0

-

Goodwill

-

0

1,563

-

-

Goodwill

-

0

1,563

0

-

Other assets

-

0

49

0

-

Accrued interest on notes payable utilized to exercise warrants

-

-

-

-

93

Fair value of warrants issued in conversion of accounts payable

-

-

-

-

7